Cite
HARVARD Citation
Bando, H. et al. (n.d.). 1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients. European journal of cancer. pp. S316-. [Online].